| Name | Title | Contact Details |
|---|---|---|
Matt Berkle |
Head of U.S. Compliance | Profile |
Headquartered in Redmond, WA, Medstreaming is a leading provider of Healthcare IT (“HCIT”) solutions for image intensive specialties. We are focused on enabling proactive patient care and increasing the efficiency of healthcare by providing medical IT solutions to individual practitioners and large institutions alike. Since its founding in 2006, Medstreaming has become a market leader in delivering specialty-based workflow applications that function as a “best of breed” specialties, including, but not limited to, Cardiology, Vascular, Vein & Surgery. Lead by a team of founding engineers, clinical specialists, and healthcare IT veterans, Medstreaming is committed to dramatically improving the delivery of healthcare and disease management, while becoming a global leader developing medical informatics solutions.
Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia`s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women`s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
Sunrise Medical Technology is a Waxahachie, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Duffens Optical Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.